Induction of alloreactive immunosuppression by 1,4-bis [(2-aminoethyl)amino]-5,8-dihydroxy-9,10-anthracenedione dihydrochloride (CL 232,468)
โ Scribed by Bosco Shang Wang; Araceli L. Lumanglas; Veronica M. Ruszala-Mallon; Roslyn E. Wallace; Frederick E. Durr
- Publisher
- Elsevier Science
- Year
- 1984
- Tongue
- English
- Weight
- 564 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0192-0561
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
D HA Q, a new antitumor agent, has been selected for clinical trial on the basis of its activity against a number of transplantable rodent tumors. In anticipation of the clinical trial of this agent, the pharmacology of DHAQ was studied in beagles by high-pressure liquid chromatographic and radioche
An oxygen analog of the antineoplastic anthraquinone, 1,4-dihydroxy-5,8-bis[ [2-(2-hydroxyethyl)amino]ethyl)amino -9,lO -anthracenedione, was synthesized. This compound, 1,4-dihydroxy-5,8bis[ [2-(2-hydroxyethoxy)ethyI]amino] -9,10-anthracenedione, was found to be inactive against P-388 lymphocytic l